Home > Publications database > Cancer-Related Fatigue: Causes and Current Treatment Options. > print |
001 | 153596 | ||
005 | 20240229123045.0 | ||
024 | 7 | _ | |a 10.1007/s11864-020-0707-5 |2 doi |
024 | 7 | _ | |a pmid:32025928 |2 pmid |
024 | 7 | _ | |a 1527-2729 |2 ISSN |
024 | 7 | _ | |a 1534-6277 |2 ISSN |
024 | 7 | _ | |a altmetric:75330815 |2 altmetric |
037 | _ | _ | |a DKFZ-2020-00340 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Thong, Melissa |0 P:(DE-He78)24fe6057396bec79d2638615b12eb989 |b 0 |e First author |u dkfz |
245 | _ | _ | |a Cancer-Related Fatigue: Causes and Current Treatment Options. |
260 | _ | _ | |a Philadelphia, Pa. |c 2020 |b Current Science |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1636021828_31474 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:C071#LA:C071# |
520 | _ | _ | |a Cancer-related fatigue (CRF) is a problem for a significant proportion of cancer survivors during and after active cancer treatment. However, CRF is underdiagnosed and undertreated. Interventions are available for CRF although there is no gold standard. Based on current level of evidence, exercise seems to be most effective in preventing or ameliorating CRF during the active- and posttreatment phases. |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a van Noorden, Cornelis J F |0 0000-0002-6191-0505 |b 1 |
700 | 1 | _ | |a Steindorf, Karen |0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756 |b 2 |u dkfz |
700 | 1 | _ | |a Arndt, Volker |0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0 |b 3 |e Last author |u dkfz |
773 | _ | _ | |a 10.1007/s11864-020-0707-5 |g Vol. 21, no. 2, p. 17 |0 PERI:(DE-600)2090563-4 |n 2 |p 17 |t Current treatment options in oncology |v 21 |y 2020 |x 1534-6277 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:153596 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)24fe6057396bec79d2638615b12eb989 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CURR TREAT OPTION ON : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | 2 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 1 |
920 | 1 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 0 |
920 | 1 | _ | |0 I:(DE-He78)C110-20160331 |k C110 |l Bewegung, Präventionsforschung und Krebs |x 1 |
920 | 0 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C071-20160331 |
980 | _ | _ | |a I:(DE-He78)C110-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|